Extended-Spectrum Properties of CMY-30, a Val211Gly Mutant of CMY-2 Cephalosporinase

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase, was derived by mutagenesis. The hydrolytic efficiency of CMY-30 against expanded-spectrum cephalosporins was higher than that of CMY-2 due to increased k(cat) values. Findings indicate a role of the Omega loop residue 211 in determining the substrate specificities of CMYs also corroborated by modeling studies.

Knowledge Graph

Similar Paper

Extended-Spectrum Properties of CMY-30, a Val211Gly Mutant of CMY-2 Cephalosporinase
Antimicrobial Agents and Chemotherapy 2009.0
CMY-31 and CMY-36 Cephalosporinases Encoded by ColE1-Like Plasmids
Antimicrobial Agents and Chemotherapy 2009.0
Extended-Spectrum Cephalosporinase in Acinetobacter baumannii
Antimicrobial Agents and Chemotherapy 2010.0
Roles of Residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in Extended-Spectrum β-Lactamase Toho-1
Antimicrobial Agents and Chemotherapy 2011.0
Plasmid-Encoded ACC-4, an Extended-Spectrum Cephalosporinase Variant from Escherichia coli
Antimicrobial Agents and Chemotherapy 2007.0
Reduced Susceptibility to Cefepime among Escherichia coli Clinical Isolates Producing Novel Variants of CMY-2 β-Lactamase
Antimicrobial Agents and Chemotherapy 2009.0
Role of the Ser-287-Asn Replacement in the Hydrolysis Spectrum Extension of AmpC β-Lactamases in Escherichia coli
Antimicrobial Agents and Chemotherapy 2009.0
Biochemical Characterization of Metallo-β-Lactamase VIM-11 from a Pseudomonas aeruginosa Clinical Strain
Antimicrobial Agents and Chemotherapy 2008.0
New Variant of CTX-M-Type Extended-Spectrum β-Lactamases, CTX-M-71, with a Gly238Cys Substitution in a K lebsiella pneumoniae Isolate from Bulgaria
Antimicrobial Agents and Chemotherapy 2009.0
E240V Substitution Increases Catalytic Efficiency toward Ceftazidime in a New Natural TEM-Type Extended-Spectrum β-Lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens Clinical Isolates
Antimicrobial Agents and Chemotherapy 2008.0